| Primary |
| Drug Use For Unknown Indication |
17.9% |
| Hypertension |
10.4% |
| Bovine Tuberculosis |
9.4% |
| Cystitis |
7.5% |
| Urinary Tract Infection |
6.6% |
| Diverticulitis |
5.7% |
| Chronic Obstructive Pulmonary Disease |
4.7% |
| Diarrhoea |
3.8% |
| Helicobacter Infection |
3.8% |
| Pneumonia |
3.8% |
| Renal Failure |
3.8% |
| Anaemia |
2.8% |
| Epididymitis |
2.8% |
| Ischaemic Heart Disease Prophylaxis |
2.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.8% |
| Pyrexia |
2.8% |
| Schizophrenia, Paranoid Type |
2.8% |
| Analgesic Therapy |
1.9% |
| Atrial Fibrillation |
1.9% |
| Back Pain |
1.9% |
|
| Weight Decreased |
18.8% |
| Rhabdomyolysis |
9.4% |
| Vomiting |
9.4% |
| Intestinal Haemorrhage |
6.3% |
| Ventricular Fibrillation |
6.3% |
| Visual Impairment |
6.3% |
| Hepatic Function Abnormal |
3.1% |
| Hypoaesthesia |
3.1% |
| Hypokalaemia |
3.1% |
| Infection Susceptibility Increased |
3.1% |
| Local Swelling |
3.1% |
| Malaise |
3.1% |
| Pain In Extremity |
3.1% |
| Peripheral Nerve Paresis |
3.1% |
| Rash |
3.1% |
| Renal Failure Acute |
3.1% |
| Respiratory Failure |
3.1% |
| Restlessness |
3.1% |
| Septic Shock |
3.1% |
| Shock |
3.1% |
|
| Secondary |
| Hypertension |
18.2% |
| Drug Use For Unknown Indication |
14.5% |
| Product Used For Unknown Indication |
11.3% |
| Pneumonia |
6.3% |
| Urinary Tract Infection |
5.7% |
| Infection |
4.4% |
| Helicobacter Infection |
3.8% |
| Pyrexia |
3.8% |
| Thrombosis Prophylaxis |
3.8% |
| Anaemia |
3.1% |
| Coronary Arterial Stent Insertion |
3.1% |
| Diverticulitis |
3.1% |
| Bacterial Infection |
2.5% |
| Cystitis |
2.5% |
| Gastroenteritis |
2.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.5% |
| Renal Failure |
2.5% |
| Wound Treatment |
2.5% |
| Acute Myeloid Leukaemia |
1.9% |
| Bacteraemia |
1.9% |
|
| Toxic Epidermal Necrolysis |
15.2% |
| Rash |
12.1% |
| Gastroenteritis Clostridial |
6.1% |
| Hypokalaemia |
6.1% |
| Renal Failure Acute |
6.1% |
| Skin Infection |
6.1% |
| Urinary Tract Infection |
6.1% |
| Ventricular Fibrillation |
6.1% |
| Dehydration |
3.0% |
| Drug Interaction |
3.0% |
| Hallucination |
3.0% |
| Hepatic Function Abnormal |
3.0% |
| Leukopenia |
3.0% |
| Pain In Extremity |
3.0% |
| Procalcitonin Increased |
3.0% |
| Pyrexia |
3.0% |
| Respiratory Failure |
3.0% |
| Retinal Detachment |
3.0% |
| Stent Placement |
3.0% |
| Stevens-johnson Syndrome |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.0% |
| Drug Use For Unknown Indication |
11.0% |
| Prophylaxis Against Transplant Rejection |
9.8% |
| Colon Cancer Metastatic |
8.2% |
| Prophylaxis |
5.9% |
| Acute Myeloid Leukaemia |
3.9% |
| Breast Cancer |
3.5% |
| Hypertension |
3.1% |
| Infection Prophylaxis |
2.9% |
| Malignant Melanoma |
2.5% |
| Crohn's Disease |
2.3% |
| B-cell Lymphoma |
2.2% |
| Colorectal Cancer Metastatic |
2.2% |
| Pain |
2.2% |
| Sleep Disorder |
2.2% |
| Glioblastoma |
2.0% |
| Urinary Tract Infection |
2.0% |
| Immunosuppression |
1.8% |
| Nausea |
1.8% |
| Tumour Pain |
1.8% |
|
| Urinary Tract Infection |
17.5% |
| Urosepsis |
12.5% |
| Thrombocytopenia |
6.3% |
| Toxic Epidermal Necrolysis |
6.3% |
| Urinary Retention |
6.3% |
| Pneumonia |
5.0% |
| Vomiting |
5.0% |
| Pneumonia Primary Atypical |
3.8% |
| Renal Failure |
3.8% |
| Renal Failure Acute |
3.8% |
| Sepsis |
3.8% |
| Soft Tissue Infection |
3.8% |
| Visual Acuity Reduced |
3.8% |
| Wound Dehiscence |
3.8% |
| Autoimmune Thrombocytopenia |
2.5% |
| Basal Cell Carcinoma |
2.5% |
| Migraine |
2.5% |
| Panic Attack |
2.5% |
| Peritonitis |
2.5% |
| Pleural Effusion |
2.5% |
|
| Interacting |
| Cardiac Failure |
30.0% |
| Hypertension |
20.0% |
| Schizoaffective Disorder |
20.0% |
| Atrial Fibrillation |
10.0% |
| Gastroenteritis |
10.0% |
| Hypothyroidism |
10.0% |
|
| Hypersensitivity |
28.6% |
| Respiratory Failure |
28.6% |
| White Blood Cells Urine Positive |
28.6% |
| Atrial Fibrillation |
14.3% |
|
